Changes and clinical significance of thyroid hormones function in elderly patients with chronic heart failure

ZHOU Qina DU Wenjuan

Medical Journal of the Chinese People Armed Police Forces ›› 2014, Vol. 25 ›› Issue (10) : 997-998.

PDF(389 KB)
PDF(389 KB)
Medical Journal of the Chinese People Armed Police Forces ›› 2014, Vol. 25 ›› Issue (10) : 997-998.
ORIGINAL ARTICLES

Changes and clinical significance of thyroid hormones function in elderly patients with chronic heart failure

  • ZHOU Qina1 DU Wenjuan2
Author information +
History +

Abstract

Objective To investigate the changes and clinical significance of thyroid hormones function in elderly patients with chronic heart failure. Methods A total of 76 elderly patients with chronic heart failure were divided into different groups according to NYHA categorization: NYHA Ⅱ group (25 patients), NYHA Ⅲ group (28 patients) and NYHA IV group (23 patients). Thirty non-heart failure elderly subjects served as control group. T3, T4, FT4, FT3, TSH were tested by radioimmunoassay. Results Compared with T3 and FT3 levels [(2.34±0.52)nmol/L and (4.27±0.64) pmol/L respectively] in control group, T3 and FT3 levels[(1.28±0.51) nmol/L and (3.01±0.78) pmol/L respectively] in NYHAⅡ group were decreased (P<0.05); and with the deterioration of cardiac function functional class Ⅲ-Ⅳ (P<0.01), patients showed T3 and FT3 levels [ (0.87±0.43) nmol/L and (2.42±0.61) pmol/L respectively] in NYHA Ⅲ group, and [ (0.60±0.36) nmol/L and (2.09±0.71) pmol/L respectively ] in NYHA IV group. Conclusions T3 and FT3 play an important role in chronic heart failure, can serve as the early predictors in elderly patients with chronic heart failure.

Key words

elderly patients / chronic heart failure / thyroid hormones / clinical significance

Cite this article

Download Citations
ZHOU Qina DU Wenjuan. Changes and clinical significance of thyroid hormones function in elderly patients with chronic heart failure[J]. Medical Journal of the Chinese People Armed Police Forces. 2014, 25(10): 997-998

References

[1] 王 林.老年人慢性心力衰竭治疗进展[J].岭南心血管病杂志,2011,17(3):178-182.
[2] 黄震华.甲状腺激素与心力衰竭[J].中国新药与临床杂志,2013,32(9):692-695.
[3] 中华医学会心血管病分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗指南[J]. 中华心血管病杂志, 2007,35 (12 ):1076-1095.
[4] 潘鑫辉,张 浒,李德昶.65岁以上老年心力衰竭185例诊治分析[J].齐齐哈尔医学院学报,2013,34(11):1583-1584.
[5] 廖 华,郭小梅.慢性心力衰竭诊断与治疗新进展[J]. 心血管病学进展,2011,32(1):94-97.
[6] 高 莹,郭晓蕙.老年人甲状腺功能异常与心血管疾病[J].中华老年多器官疾病杂志,2013,12(4):263-269.
[7] 唐熠达.甲状腺与心血管疾病[M].长沙:中南大学出版社,2012:17.
[8] 张庆峰,邹金海,王 建,等. CHF患者甲状腺激素动态观察及预后[J]. 放射免疫学杂志,2009,22(4):357-358.
[9] 李 鉴.慢性充血性心力衰竭患者甲状腺激素含量变化的意义[J].中国实用内科杂志,2010,30(增刊1):52-53.
PDF(389 KB)

Accesses

Citation

Detail

Sections
Recommended

/